Skip to main content

Want a detailed portfolio tracker?

Cns Pharmaceuticals (CNSP) P/E (2024 - 2026)

Cns Pharmaceuticals (CNSP) P/E from Jul 1, 2024 to Jul 21, 2026. The TTM Cns Pharmaceuticals (CNSP) P/E is -0.21. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cns Pharmaceuticals (CNSP)

YearP/EChange
2026-0.21+48.18%
2025-0.14-70.99%
2024-0.49N/A

Comparison Cns Pharmaceuticals (CNSP) P/E with competitors

Cns Pharmaceuticals (CNSP) P/E is -0.21.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.81%
NBYStablecoin Development Corp0.00-102.06%
ENLVEnlivex Ltd0.07-135.82%
FGENFibroGen Inc0.24-214.95%
CHRSCoherus Biosciences Inc0.85-506.35%
FBIOFortress Biotech Inc0.95-554.48%
ORMPOramed Pharmaceuticals Inc1.50-819.80%
AGENAgenus Inc3.01-1541.28%
INVAInnoviva Inc3.15-1610.43%
VXRTVaxart Inc3.55-1799.93%
CRMDCorMedix Inc3.63-1837.62%
CVACCureVac N.V.4.45-2228.99%
GLPGGalapagos NV4.86-2426.87%
SRPTSarepta Therapeutics Inc4.88-2437.98%
ABEOAbeona Therapeutics Inc5.39-2680.03%
ABUSArbutus Biopharma Corp5.60-2779.69%
ZVRAZevra Therapeutics Inc5.89-2919.34%
SPROSpero Therapeutics Inc6.23-3082.74%
CGENCompugen Ltd6.31-3123.69%
RIGLRigel Pharmaceuticals6.87-3390.97%
SLXNSilexion Therapeutics Corp7.30-3594.02%
OMEROmeros Corporation9.26-4533.93%
AUPHAurinia Pharmaceuticals Inc9.58-4690.15%
PLXProtalix BioTherapeutics Inc10.89-5315.60%
ACADAcadia Pharmaceuticals Inc11.73-5716.69%
TBPHTheravance Biopharma Inc12.26-5972.24%
ADMAAdma Biologics Inc12.42-6046.95%
HRMYHarmony Biosciences Holdings Inc13.82-6718.38%
SABSSAB Biotherapeutics Inc14.14-6869.71%
NAGENiagen Bioscience Inc14.82-7196.28%
INCYIncyte Corp15.82-7677.30%
REGNRegeneron Pharmaceuticals Inc15.86-7693.63%
PBYIPuma Biotechnology Inc17.32-8392.35%
CPRXCatalyst Pharmaceuticals Inc17.44-8451.55%
EXELExelixis Inc17.54-8498.82%
TGTXTG Therapeutics Inc18.97-9182.70%
MDXGMimedx Group Inc20.55-9942.44%
XOMAXOMA Royalty Corp22.87-11054.80%
ARGXArgen X SE24.30-11736.43%
CTMXCytomX Therapeutics Inc24.82-11986.95%
XOMAOXOMA Royalty Corp25.34-12237.75%
HALOHalozyme Therapeutics Inc25.62-12371.32%
XOMAPXOMA Royalty Corp25.67-12393.54%
VRTXVertex Pharmaceuticals Inc27.99-13506.81%
RPRXRoyalty Pharma plc - Class A28.69-13838.60%
SLNOSoleno Therapeutics Inc29.02-13995.59%
ASNDAscendis Pharma A/S30.09-14508.12%
LGNDLigand Pharmaceuticals Inc - Class B37.91-18256.25%
APLSApellis Pharmaceuticals Inc39.02-18787.45%
BMRNBiomarin Pharmaceutical Inc42.21-20315.46%
KRYSKrystal Biotech Inc45.34-21815.21%
ONCBeiGene Ltd69.54-33403.27%
PHARPharming Group N.V.75.03-36030.13%
TECHBio-Techne Corp101.96-48928.39%
VCELVericel Corp109.92-52741.90%
ALNYAlnylam Pharmaceuticals Inc117.96-56594.10%
GMABGenmab140.29-67285.98%
TLXTelix Pharmaceuticals Ltd162.15-77755.83%
CORTCorcept Therapeutics Inc212.86-102038.57%